Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

SubscribeLogin
Published • loading... • Updated

Amgen culls early-stage obesity candidate, makes pipeline updates

Summary by endpoints.news
Amgen is cutting its secretive early-stage obesity candidate, AMG-513. The company hasn’t revealed much about the Phase 1 program or why it’s being discontinued. When asked for more detail, a spokesperson told Endpoints News on ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

endpoints.newsendpoints.news

Amgen culls early-stage obesity candidate, makes pipeline updates

Amgen is cutting its secretive early-stage obesity candidate, AMG-513. The company hasn’t revealed much about the Phase 1 program or why it’s being discontinued. When asked for more detail, a spokesperson told Endpoints News on ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news on Tuesday, August 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Amgen icon

Amgen

Thousand Oaks icon

Thousand Oaks

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal